Avantor Target of Unusually Large Options Trading (NYSE:AVTR)

Avantor, Inc. (NYSE:AVTR) was the recipient of unusually large options trading on Monday. Stock investors purchased 26,227 put options on the company. This is an increase of 384% compared to the average volume of 5,419 put options.

Institutional Investors Weigh In On Avantor

Hedge funds have recently bought and sold shares of the business. MassMutual Private Wealth & Trust FSB boosted its stake in shares of Avantor by 99.5% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock valued at $26,000 after buying an additional 625 shares during the last quarter. UMB Bank n.a. acquired a new stake in Avantor in the third quarter valued at $49,000. Global Retirement Partners LLC raised its holdings in Avantor by 76.7% in the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock valued at $52,000 after acquiring an additional 1,067 shares in the last quarter. Nisa Investment Advisors LLC boosted its stake in Avantor by 69.6% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock valued at $53,000 after acquiring an additional 835 shares during the last quarter. Finally, GAMMA Investing LLC grew its holdings in Avantor by 89.9% during the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock worth $70,000 after acquiring an additional 1,285 shares in the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently commented on AVTR. UBS Group reaffirmed a “neutral” rating and set a $25.00 price objective (down previously from $29.00) on shares of Avantor in a research note on Friday, January 17th. Barclays upped their price target on shares of Avantor from $25.00 to $26.00 and gave the stock an “overweight” rating in a research report on Monday. Wells Fargo & Company reduced their price objective on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. Raymond James reduced their target price on shares of Avantor from $29.00 to $26.00 and set an “outperform” rating on the stock in a report on Tuesday, January 21st. Finally, Robert W. Baird lowered their price target on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a report on Monday, October 28th. Three research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat.com, Avantor currently has an average rating of “Moderate Buy” and an average target price of $27.46.

Avantor Stock Up 0.7 %

Shares of NYSE AVTR opened at $22.03 on Wednesday. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.06 and a current ratio of 1.54. Avantor has a 1 year low of $19.59 and a 1 year high of $28.00. The stock’s 50-day simple moving average is $21.71 and its 200-day simple moving average is $23.47. The firm has a market cap of $14.99 billion, a price-to-earnings ratio of 47.88, a PEG ratio of 3.97 and a beta of 1.28.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.